Results 11 to 20 of about 344,007 (291)

Global Prevalence and Major Risk Factors of Diabetic Retinopathy

open access: yesDiabetes Care, 2012
OBJECTIVE To examine the global prevalence and major risk factors for diabetic retinopathy (DR) and vision-threatening diabetic retinopathy (VTDR) among people with diabetes. RESEARCH DESIGN AND METHODS A pooled analysis using individual participant data
J. Yau   +35 more
semanticscholar   +3 more sources

Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland [PDF]

open access: yesDiabetologia, 2012
The prevalence of retinopathy at first screening is lower than in previous UK studies, consistent with earlier diagnosis of diabetes. Most newly diagnosed type 2 diabetic patients in Scotland are screened within an acceptable interval and the prevalence ...
Lee, N   +56 more
core   +3 more sources

Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes

open access: yesJAMA - Journal of the American Medical Association, 2017
D. Ting   +28 more
semanticscholar   +3 more sources

Prevalence of visual impairment and severity of diabetic retinopathy in various ethnic groups in the UK [PDF]

open access: yes, 2011
Diabetic Retinopathy (DR) is a leading cause of visual impairment (VI) in the working population. Minor ethnic groups are at increased risk of diabetes.
Gupta, Bhaskar
core   +7 more sources

Assessment of retinopathy [PDF]

open access: yes, 2010
Warren Gillibrand and Phil Holdich explain the importance of screening all patients with diabetes annually for retinopathy as in the majority of cases effective treatment can be given to maintain visual ...
Holdich, Phil, Gillibrand, Warren P.
core   +4 more sources

Vessel identification in diabetic retinopathy [PDF]

open access: yes
Diabetic retinopathy is the single largest cause of sight loss and blindness in 18 to 65 year olds. Screening programs for the estimated one to six per- cent of the diabetic population have been demonstrated to be cost and sight saving, howeverthere are ...
Teng, Thomas Bart
core   +9 more sources

Effects of laser photocoagulation on serum angiopoietin-1, angiopoietin-2, angiopoietin-1/angiopoietin-2 ratio, and soluble angiopoietin receptor Tie-2 levels in type 2 diabetic patients with proliferative diabetic retinopathy [PDF]

open access: yesInternational Journal of Ophthalmology, 2014
AIM: To determine the effects of laser photocoagulation on serum levels of angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), soluble angiopoietin receptor Tie-2 (Tie-2), Ang-1/Ang-2 ratio and vascular endothelial growth factor (VEGF) in patients with type ...
Qiao-Ying You   +3 more
doaj   +1 more source

International Classification of Retinopathy of Prematurity, 3rd edition

open access: yesOphthalmology (Rochester, Minn.), 2021
Objective: The International Classification of Retinopathy of Prematurity (ICROP) is a consensus statement that creates a standard nomenclature for classification of retinopathy of prematurity (ROP).
Michael F. Chiang   +34 more
semanticscholar   +1 more source

A deep learning system for detecting diabetic retinopathy across the disease spectrum

open access: yesNature Communications, 2021
Retinal screening contributes to early detection of diabetic retinopathy and timely treatment. To facilitate the screening process, we develop a deep learning system, named DeepDR, that can detect early-to-late stages of diabetic retinopathy.
L. Dai   +19 more
semanticscholar   +1 more source

Efficacy of intravitreal AFlibercept injection For Improvement of retinal Nonperfusion In diabeTic retinopathY (AFFINITY study)

open access: yesBMJ Open Diabetes Research & Care, 2020
Introduction To evaluate the effects of intravitreal aflibercept injection on retinal nonperfusion in patients with diabetic retinopathy (DR) using ultrawide field (UWF) fluorescein angiography (FA).Research design and methods Thirty-eight eyes of 38 ...
Young Hee Yoon   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy